Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer.
Nilsson S, Strang P, Aksnes AK, Franzèn L, Olivier P, Pecking A, Staffurth J, Vasanthan S, Andersson C, Bruland ØS. Nilsson S, et al. Among authors: pecking a. Eur J Cancer. 2012 Mar;48(5):678-86. doi: 10.1016/j.ejca.2011.12.023. Epub 2012 Feb 15. Eur J Cancer. 2012. PMID: 22341993 Free article. Review.
[Pain and bone metastases].
Wassermann J, De La Lande B, Pecking A, Brasseur L. Wassermann J, et al. Among authors: pecking a. Prog Urol. 2008 Nov;18 Suppl 7:S399-409. doi: 10.1016/S1166-7087(08)74574-3. Prog Urol. 2008. PMID: 19070823 French.
Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial.
Serafini AN, Houston SJ, Resche I, Quick DP, Grund FM, Ell PJ, Bertrand A, Ahmann FR, Orihuela E, Reid RH, Lerski RA, Collier BD, McKillop JH, Purnell GL, Pecking AP, Thomas FD, Harrison KA. Serafini AN, et al. Among authors: pecking ap. J Clin Oncol. 1998 Apr;16(4):1574-81. doi: 10.1200/JCO.1998.16.4.1574. J Clin Oncol. 1998. PMID: 9552068 Clinical Trial.
Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studies.
Serafini AN, Klein JL, Wolff BG, Baum R, Chetanneau A, Pecking A, Fischman AJ, Hoover HC Jr, Wynant GE, Subramanian R, Goroff DK, Hanna MG Jr. Serafini AN, et al. Among authors: pecking a. J Clin Oncol. 1998 May;16(5):1777-87. doi: 10.1200/JCO.1998.16.5.1777. J Clin Oncol. 1998. PMID: 9586891 Clinical Trial.
Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium Tc 99m 88BV59H21-2V67-66 (HumaSPECT-Tc), a totally human monoclonal antibody. Patient management benefit from a phase III multicenter study.
Wolff BG, Bolton J, Baum R, Chetanneau A, Pecking A, Serafini AN, Fischman AJ, Hoover HC Jr, Klein JL, Wynant GE, Subramanian R, Goroff DK, Hanna MG Jr. Wolff BG, et al. Among authors: pecking a. Dis Colon Rectum. 1998 Aug;41(8):953-62. doi: 10.1007/BF02237380. Dis Colon Rectum. 1998. PMID: 9715149 Clinical Trial.
78 results